v3.22.2.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:    
Net loss $ (73,151) $ (58,583)
Adjustments to reconcile net loss to net cash flows from operating activities:    
Amortization and depreciation 7,128 6,450
Amortization of debt issuance costs 1,563 1,319
Bad debt reserve 4,926 4,783
Loss on change in fair value of warrants 606
Equity-based compensation 543 468
Phantom unit expense 7,242 271
Gain on forgiveness of debt (10,900)
Deferred income tax benefit (1,720) (1,144)
Change in operating assets and liabilities (net of effects of acquisitions):    
Accounts receivable (2,567) (10,235)
Contract assets (13,627) 11,731
Other current assets 117 (1,557)
Prepaid expenses (2,470) 695
Operating lease assets (36) 716
Accounts payable 5,616 15,099
Accrued expenses 16,670 (863)
Other noncurrent assets (89) (601)
Contract liabilities 610 1,114
Operating lease liabilities (522) (1,176)
Other liabilities 200 31
Net Cash used in Operating Activities (59,861) (31,482)
Cash flows from investing activities:    
Property and equipment purchases (1,971) (1,288)
Intangible asset purchases (2,031) (218)
Net Cash used in Investing Activities (4,002) (1,506)
Cash flows from financing activities:    
Net borrowings (payments) on line of credit 543 (6,578)
Proceeds from long-term debt 42,254 30,778
Repayments of long-term debt (3,000) (2,254)
Financing costs paid (2,771) (603)
Proceeds from warrant exercise 32,490
Payments of deferred offering costs (1,057)
Net Cash provided by Financing Activities 68,459 21,343
Net change in cash 4,596 (11,645)
Cash at the beginning of the period 6,021 17,666
Cash at the end of the period 10,617 6,021
Supplemental disclosure of cash flow information:    
Cash paid for interest 8,366 6,413
Fair value of warrants issued as debt discount $ 773